[go: up one dir, main page]

PT73593A - Procede de preparation de derives d'aminothiols leur utilisation ainsi que compositions contenant ces derives - Google Patents

Procede de preparation de derives d'aminothiols leur utilisation ainsi que compositions contenant ces derives

Info

Publication number
PT73593A
PT73593A PT73593A PT7359381A PT73593A PT 73593 A PT73593 A PT 73593A PT 73593 A PT73593 A PT 73593A PT 7359381 A PT7359381 A PT 7359381A PT 73593 A PT73593 A PT 73593A
Authority
PT
Portugal
Prior art keywords
derivatives
preparation
compositions containing
aminothiol
aminothiol derivatives
Prior art date
Application number
PT73593A
Other languages
English (en)
Portuguese (pt)
Other versions
PT73593B (fr
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of PT73593A publication Critical patent/PT73593A/fr
Publication of PT73593B publication Critical patent/PT73593B/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT73593A 1980-08-29 1981-08-28 Procede de preparation de derives d'aminothiols leur utilisation ainsi que compositions contenant ces derives PT73593B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU82738A LU82738A1 (fr) 1980-08-29 1980-08-29 Derives d'aminothiols,leur preparation et utilisation ainsi que compositions contenant ces derives

Publications (2)

Publication Number Publication Date
PT73593A true PT73593A (fr) 1981-09-01
PT73593B PT73593B (fr) 1982-11-10

Family

ID=19729472

Family Applications (1)

Application Number Title Priority Date Filing Date
PT73593A PT73593B (fr) 1980-08-29 1981-08-28 Procede de preparation de derives d'aminothiols leur utilisation ainsi que compositions contenant ces derives

Country Status (18)

Country Link
JP (1) JPS5798255A (fr)
AU (1) AU7465481A (fr)
BE (1) BE890116A (fr)
DE (1) DE3133293A1 (fr)
DK (1) DK382281A (fr)
ES (1) ES505037A0 (fr)
FI (1) FI812640L (fr)
FR (1) FR2489325A1 (fr)
GB (1) GB2083036A (fr)
GR (1) GR74348B (fr)
IL (1) IL63664A0 (fr)
IT (1) IT1137642B (fr)
LU (1) LU82738A1 (fr)
NL (1) NL8103993A (fr)
NO (1) NO812944L (fr)
PT (1) PT73593B (fr)
SE (1) SE8104958L (fr)
ZA (1) ZA815912B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
US4638051A (en) * 1984-04-30 1987-01-20 The Johns Hopkins University Brain imaging radiopharmaceuticals

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2505870A (en) * 1947-05-09 1950-05-02 Phillips Petroleum Co Secondary and tertiary alkylthiol amines and their production
US3337625A (en) * 1961-09-18 1967-08-22 Lilly Co Eli Amino-acetylenic compounds
US3312732A (en) * 1962-02-28 1967-04-04 Monsanto Res Corp Aminoalkyl aminoalkanethiols
US3356730A (en) * 1964-11-25 1967-12-05 Monsanto Res Corp Mercaptoalkyl oxyalkyl amines
GB1138738A (en) * 1966-12-01 1969-01-01 Eastman Kodak Co Aziridine derivatives
US3622676A (en) * 1968-11-20 1971-11-23 Constance Anthony D Alonzo Smoking suppression
CA992105A (en) * 1970-03-26 1976-06-29 Exxon Research And Engineering Company Polythioethers formed by anionic ring opening of episulfides
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
CH632906A5 (en) * 1976-08-09 1982-11-15 Givaudan & Cie Sa Use of bifunctional N,S-compounds as flavourings

Also Published As

Publication number Publication date
SE8104958L (sv) 1982-03-01
GR74348B (fr) 1984-06-26
LU82738A1 (fr) 1982-05-10
DE3133293A1 (de) 1982-04-08
AU7465481A (en) 1982-03-04
DK382281A (da) 1982-03-01
ES8307735A1 (es) 1983-08-16
FR2489325A1 (fr) 1982-03-05
FI812640L (fi) 1982-03-01
IT8123611A0 (it) 1981-08-24
ES505037A0 (es) 1983-08-16
PT73593B (fr) 1982-11-10
ZA815912B (en) 1982-08-25
IL63664A0 (en) 1981-11-30
JPS5798255A (en) 1982-06-18
BE890116A (fr) 1982-03-01
NL8103993A (nl) 1982-03-16
NO812944L (no) 1982-03-01
IT1137642B (it) 1986-09-10
GB2083036A (en) 1982-03-17

Similar Documents

Publication Publication Date Title
MA19639A1 (fr) Procede de preparation de derives de l'acide cis, endo-2-azabicyclo- (3,3,0) -octane-3- carboxylique et d'agents contenant ces derives
PT72435B (pt) Process for the preparation of 2-<2-(1,4-benzodioxanyl)>-2-imi-dazoline and salts thereof having pharmaceutical effect
SE7806514L (sv) Procede de fabrication d'un silico aluminate alcalin cristallin, produit obtenu et application
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
BE879472A (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
FI790922A (fi) 2,6-dialkoxibenzamider mellanprodukter farmaceutiska kompositioner och foerfarande foer behandling av psykotiska sjukdomar
BE883068A (fr) Derives de benzimidazole, leur preparation, et utilisation ainsi que compositions contenant ces derives
ES511220A0 (es) "procedimiento de preparacion de nuevos derivados 4-aminoetoxi-5-isopropil-2-metil".
RO81685A (fr) Procede de preparation des derives d'antraquinonsulfonamides
RO83114A (fr) Procede pour preparer dithiazolyl-(2,2')-disulfures
IL64880A (en) Derivatives of 1,4-benzodioxanyl imidazoline,processes for the preparation thereof and pharmaceutical compositions containing the same
IT1194793B (it) Derivati tiazolidinici ad attivita' farmacologica,procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati
BE875378A (fr) Procede de preparation d'alcoylsilanes
BE880509A (fr) Procede de preparation de 2',6'-dialkyl-n-alcoxymethyl-2-chloro-acetanilides
PT73593A (fr) Procede de preparation de derives d'aminothiols leur utilisation ainsi que compositions contenant ces derives
PT77751A (fr) Procede de preparation de derives benzylideniques soufres et de compositions pharmaceutiques le contenant
FR2595697B1 (fr) Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
BE860162A (fr) Derives actifs de l'uree leur procede de preparation ainsi que les compositions therapeutiques les contenant
IT8024152A0 (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
LU79157A1 (fr) Procede de preparation de nouveaux derives de l'oxadiazole-1,3,4 et de compositions fongicides les contenant
FR2513485B1 (fr) Herbicides contenant des derives carboxamido-thiocarbamates et procede pour la preparation des constituants actifs de ces herbicides
RO84910A (fr) Procede pour la preparation des derives 1,1-dioxydes de l'acide 6-aminoalkylpenycillanique
BE893696A (fr) Imidazolyl-propionitriles, leur procede de preparation et compositions contenant ces composes
NO158299C (no) Analogifremgangsmaate for fremstilling av 17, 18-dehydro-apovincaminol-l-3', 4', 5'-trimethoxy-benzoat.
BE842528R (fr) Derives actifs de methylamine, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions